Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHBDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SSH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UROD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1M2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RECQL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMG20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RHPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724660 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00672 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on